top of page
Delivering for our partners
CSI has delivered comparator medicines, medical devices and ancillaries to thousands of clinical trials around the world. Our extensive experience and global reach mean we can advise our partners on the best strategy for supplying any study – whether this involves direct-to-site shipments, local or regional depots, or hybrid solutions – to ensure the necessary products arrive on time, within budget, and at the required location.
We understand the challenges of managing a complex clinical trial supply chain and can deliver to your site, warehouse or packaging agent. CSI’s integrated, end-to-end distribution solutions allow our partners to maintain focus on the drug development process, keeping studies flexible, agile and on schedule.
Storage and Distribution
Strategically positioned global depot network
International clinical trials require global facilities in strategic regions combined with local insight and experience of a variety of regulatory requirements. CSI’s global depot network spans 60 countries and six continents, allowing us to identify the most cost-effective solutions for any trial supply, while maintaining flexibility and allowing for contingencies.
Our Global Reach
Warehouses and offices
Our network extends to 60 countries on six continents
Global expertise with unrivalled global knowledge
CSI is headquartered in London and has offices in the United Kingdom, United States, Germany and Israel. Delivering clinical trial supplies to some of the world’s most difficult-to-reach markets, our experienced and knowledgeable teams have comprehensive knowledge of import and export logistics, as well as the movement of investigational medicinal products (IMPs) across all global markets. Our international reach ensures we can source the clinical supplies needed for even the most complex trials and deliver them on time and within budget.
We overcome distribution challenges
CSI’s flexible clinical trial supply strategies ensure we can overcome any distribution challenges that might affect the outcome of our partners’ clinical trials, including:
Breakdowns in the logistical supply chain
Slow-paced patient recruitment
Fluctuation in demand
Our clinical distribution strategy covers logistical planning, imports, exports and inventory shelf-life control, and our centralised compliance team oversees the entire study. This reduces vendor complexity and ensures clinical supplies are delivered within the agreed timeframe.
For open label studies, CSI can deliver directly to sites in a fast, reliable and cost-effective manner. We work closely with project managers, assisting with trial forecasts to ensure that medication is available at all sites when needed. Our flexible and adaptive solutions help our partners to save resources and facilitate effective patient recruitment and retention.
Controlled transport and storage
CSI is licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Berlin State Office for Health and Social Affairs (LAGeSo). We are experts in cold chain biologic, temperature-controlled and ambient product delivery, and our quality management system ensures full compliance with regulatory requirements around the world. All our depots are audited to ensure the highest standards of Good Manufacturing Practice (GMP), while our end-to-end transport and storage services are monitored at every stage of the distribution process.
Secure shipment tracking
All CSI warehouse and shipment activities are tracked using GPS and our specialised inventory system, so we are always in control of our stock levels and can guarantee full traceability from pick-up until delivery. We provide partners with full visibility throughout the logistical process, and our tracking system efficiently flags low stock levels and impending expiry dates. We can also provide, as required, customised inventory reports that document:
Shipment and receipt date
Returns, reconciliation and destruction
CSI also handles returns and destruction at the site level. We can return damaged, expired or unused medications to our warehouses for final reconciliation destruction. We produce comprehensive final reports as part of the close-out document of the study.
bottom of page